RPS welcomes MHRA measures on sodium valproate
The RPS welcomes new measuresannounced today by the MHRA to help prevent harm to women taking sodium valproate. These include: All women of childbearing age taking part in a pregnancy prevention p (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

PPI Use and Mortality in Those With Pyogenic Liver Abscess PPI Use and Mortality in Those With Pyogenic Liver Abscess
A new study examines the impact of PPI treatment on mortality among patients with pyogenic liver abscess.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients with COPD
24 April 2018 -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

Nanomedicine: Drugs can be made 'smarter'
(University of Lincoln) A new method has been developed to make drugs 'smarter' using nanotechnology so pharmacologists can tailor their drugs to more accurately target an area on the body, such as a cancer tumour. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2018 Category: International Medicine & Public Health Source Type: news

Astellas Submits New Drug Applications for Approval of Gilteritinib for the Treatment of FLT3mut+ Relapsed or Refractory Acute Myeloid Leukemia
TOKYO, April 23, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., " Astellas " ) today announced that it submitted on March 23, 2018, a new drug application (NDA) for marketing approval of gilteritinib... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 23, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis
INDIANAPOLIS, April 23, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration's (FDA) Arthritis Advisory Committee recommended approval of the 2-mg... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 23, 2018 Category: Drugs & Pharmacology Source Type: news

Sage Therapeutics Submits New Drug Application to U.S. FDA for Intravenous Brexanolone in the Treatment of Postpartum Depression
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 23, 2018-- Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the Company has... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 23, 2018 Category: Drugs & Pharmacology Source Type: news

Pfizer Granted FDA Breakthrough Therapy Designation for Trumenba (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years
Monday, April 23, 2018 - Pfizer Inc. (NYSE: PFE) today announced that Trumenba (Meningococcal Group B Vaccine) received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for active immunization to prevent invasive... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 23, 2018 Category: Drugs & Pharmacology Source Type: news

Zolpidem Tartrate (Edluar) Sublingual Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Dorzolamide Hydrochloride/Timolol Maleate Ophthalmic Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Dorzolamide Hydrochloride Ophthalmic Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Supporting community pharmacy contractors in working towards General Data Protection Regulation (GDPR) compliance
In just over one months’ time (25 May 2018) the two year implementation period for GDPR will end, and GDPR will be applicable. The RPS has been part of the cross-sector Community Pharmacy GDPR (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

The NHS is turning 70
The National Health Service is turning 70 on 5 July 2018. This is an opportunity to celebrate its achievements and to appreciate the vital role the service plays in all our lives. Pharmacists have p (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Exparel (Bupivacaine Liposome Injectable Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Semprex D (Acrivastine and Pseudoephedrine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Acetadote (Acetylcysteine Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Afinitor Disperz (Everolimus Tablets for Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Ethamolin (Ethanolamine Oleate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting
Lugano, Switzerland April 20, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of Akynzeo... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Potassium Chloride Injection (Updated - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

Lo-Zumandimine (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

IsonaRif (Rifampin and Isoniazid Capsules ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy
LONDON and CARLSBAD, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ( “GW”, “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

Opioid Use in GI Diagnoses vs Unexplained GI Symptoms Opioid Use in GI Diagnoses vs Unexplained GI Symptoms
How does the opioid prescription rate compare between patients with unexplained gastrointestinal symptoms and those with structural diagnoses?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Erectile dysfunction drugs may help treat many other conditions
(Wiley) A new British Journal of Pharmacology review examines how phosphodiesterase-5 (PDE5) inhibitors, which were originally approved to treat erectile dysfunction, are finding clinical uses for a wide variety of conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

Which pain medication is safest for arthritis patients?
(Wiley) In a recent Alimentary Pharmacology& Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves Tagrisso (osimertinib) as First-Line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer
18 April 2018 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Eflornithine Hydrochloride (Vaniqa) Cream (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Trandolapril Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Class 4 Medicines Defect Information: Inhixa solution for injection in pre-filled syringe (enoxaparin sodium)
The Medicines and Healthcare products Regulatory Agency (MHRA) has issues a Class 4 medicines defect information drug alert for Inhixa solution for injection in pre-filled syringes. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

AfterPill (Levonorgestrel) Tablet, 1.5 mg) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

() - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Aftera (Levonorgestrel Tablet) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 18, 2018 Category: Drugs & Pharmacology Source Type: news

Dennis M. Fisher, MD, a Highly Regarded Clinical Pharmacology and...
NDA Partners Chairman Carl Peck, MD, announced today that Dennis Fisher, MD, a highly regarded PKPD expert with more than 30 years of experience in clinical pharmacology, pharmacokinetic analysis,...(PRWeb April 18, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15414812.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 18, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Crysvita (burosumab-twza) for X-Linked Hypophosphatemia
April 17, 2018 -- The U.S. Food and Drug Administration today approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare, inherited form of rickets. XLH... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

Ondansetron Hydrochloride Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to BBC 1 about medicines for heartburn
RPS Deputy Chief Scientist Dr Claire Thompson appeared on BBC1’s Health: Truth or Scare this morning for an item investigating medicines for heartburn and what the risks are when taking proton p (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

RPS produces professional guidance for Sildenafil 50 mg film-coated tablets, P medicine (Viagra Connect)
Sildenafil 50 mg film-coated tablets were reclassified from a prescription only medicine (POM) to a Pharmacy medicine (P) in November 2017, following a public MHRA consultation. The outcome of the con (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

Vedolizumab-treated CD Patients Undergoing Abdominal Surgery Vedolizumab-treated CD Patients Undergoing Abdominal Surgery
Biologic therapies are known to increase infection risk. How does vedolizumab impact the incidence of postoperative infectious complications among Crohn's disease patients?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Provides Full Approval to Praxbind (idarucizumab), Specific Reversal Agent for Pradaxa
Ridgefield, Conn., April 17, 2018 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has provided full approval for Praxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
SOUTH SAN FRANCISCO, Calif., April 17, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved Tavalisse (fostamatinib disodium hexahydrate) for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Vonvendi [von Willebrand factor (recombinant)] for Perioperative Management of Bleeding in Adult Patients with von Willebrand Disease
Cambridge, Ma. – April 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare disease, today announced the U.S. Food and Drug Administration (FDA) has approved Vonvendi [von Willebrand factor (recombinant)], a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

Androxy (Fluoxymesterone Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 16, 2018 Category: Drugs & Pharmacology Source Type: news

New law on dispensing errors comes into force today
A new defence around inadvertent dispensing errors has come into force today (16 April), creating a safer environment for patients. After a long-running campaign from RPS and the pharmacy profession, (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) Combination as First-Line Treatment for Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma
PRINCETON, N.J.--(BUSINESS WIRE) April 16, 2018 --Bristol-Myers Squibb Company (NYSE: BMY) today announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Grants Breakthrough Therapy Designation For Genentech ’s Hemlibra (emicizumab-kxwh) in Hemophilia A Without Inhibitors
South San Francisco, CA -- April 16, 2018 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 16, 2018 Category: Drugs & Pharmacology Source Type: news

Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
DUBLIN, April 16, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALKS 5461, a novel, once-daily, oral investigational... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 16, 2018 Category: Drugs & Pharmacology Source Type: news

Talwin (Pentazocine Lactate Injection, USP, CIV) (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 13, 2018 Category: Drugs & Pharmacology Source Type: news